高血压个体中甲状腺乳头状癌与原发性醛固酮增多症的关联
本研究采用倾向评分匹配的病例对照设计,在137例甲状腺乳头状癌(PTC)合并高血压患者与137例年龄、性别、体重指数匹配的高血压对照中探讨原发性醛固酮增多症(PA)的关联。未按高血压分期匹配时两组PA患病率无显著差异(29.20% vs 20.44%,P=.093),但按高血压分期匹配后PTC组PA患病率显著高于对照组(9.56%,P<.0001)。多因素分析显示PTC与PA独立相关,作者提出将PTC合并高血压作为PA筛查的新推荐。
要点
- 未按高血压分期匹配时,PTC组PA患病率29.20%,对照组20.44%,差异无统计学显著(P=.093)。
- PTC组重度高血压(III期或难治性)频率23%,显著低于高血压对照组的73%(P<.001)。
- 按高血压分期匹配后,PTC组PA患病率显著高于对照组(9.56%,95%CI 5.39%-16.1%,P<.0001)。
核心结论
- 在高血压个体中,甲状腺乳头状癌是与原发性醛固酮增多症诊断独立相关的变量。
- 作者提出将甲状腺乳头状癌合并高血压作为PA筛查的新推荐,不论高血压严重程度。
研究设计与样本
- 倾向评分匹配的病例对照研究,纳入137例甲状腺乳头状癌合并高血压患者,对照组为137例年龄、性别、体重指数1:1匹配的高血压个体。
- 另进行二次分析,对照组还按高血压分期进行匹配。
主要发现
- 未按高血压分期匹配时,PTC组PA患病率29.20%(95%CI 21.91%-37.68%),对照组20.44%(95%CI 14.22%-28.35%),P=.093。
- PTC组重度高血压(III期或难治性)频率23%,显著低于高血压对照组的73%(P<.001)。
- 按高血压分期匹配后,PTC组PA患病率显著高于高血压对照组(9.56%,95%CI 5.39%-16.1%,P<.0001)。
- 多因素分析中,未匹配高血压个体中PTC与PA独立相关(OR 4.74;95%CI 2.26-10.55;P<.001)。
- 按高血压分期匹配的个体中,PTC与PA独立相关(OR 5.88;95%CI 2.79-13.37;P<.001)。
临床怎么用
- 作者提出将甲状腺乳头状癌合并高血压作为PA筛查的新推荐,不论高血压严重程度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Aldosterone excess chronically induces oxidative stress and cell proliferation. Previously, a single study investigated primary aldosteronism (PA) in patients with papillary thyroid cancer (PTC), albeit without a matched control group. OBJECTIVE: We conducted a propensity score-matched, case-control study to investigate the association between PA and PTC in individuals with arterial hypertension (HT). METHODS: PA was investigated in 137 patients with PTC and HT. The control group included 137 (1:1) age-, sex-, and body mass index-matched individuals with HT. We conducted a secondary analysis in which controls were also matched according to HT stage. RESULTS: The prevalence of PA was 29.20% (95% CI, 21.91%-37.68%) in the PTC group and 20.44% (95% CI, 14.22%-28.35%) in the controls not matched by HT stage (P = .093). Although the PA prevalence was similar in both groups, the frequency of severe HT (stage III or resistant) was significantly lower in the PTC group (23%) compared to the HT controls (73%; P < .001). After matching the controls by HT stage, the prevalence of PA in the PTC group was significantly higher compared to the hypertensive controls (9.56%; 95% CI, 5.39%-16.1%; P < .0001). In the multivariable analysis, PTC was independently associated with PA both in unmatched HT individuals (odds ratio [OR] 4.74; 95% CI, 2.26-10.55; P < .001) and in those matched by HT stage (OR 5.88; 95% CI, 2.79-13.37; P < .001). CONCLUSION: PTC was an independent variable associated with a diagnosis of PA in HT individuals. Therefore, we propose the association between PTC and HT as a new recommendation for PA screening regardless of HT severity.
引用
- Maciel AAW, Danilovic DLS, Soares IC, et al. Association Between Papillary Thyroid Cancer and Primary Aldosteronism in Individuals With Hypertension. J Clin Endocrinol Metab. 2025. PMID: 39292629. doi:10.1210/clinem/dgae653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。